Abstract

The newer azoles have proven to be effective in neutropenic patients with invasive pulmonary aspergillosis. However, other than surgical removal of an aspergilloma, we have no standard treatment for chronic pulmonary aspergillosis (CPA) in nonneutropenic patients. Now, researchers in France have retrospectively analyzed cases of CPA treated with voriconazole between November 2001 and May 2004. …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call